Perio Workshop 2019 develops new guidelines for treating periodontitis
BRUSSELS, Belgium: A major step forward for an evidence-based, more effective approach to the treatment of Stage I, II and III periodontitis has been the outcome of Perio Workshop 2019. The scientific meeting was organised by the European Federation of Periodontology (EFP) and was attended by more than 90 leading periodontists, dental experts and specialists in guideline development from around the world.
These specialists gathered from 10 to 12 November in La Granja de San Ildefonso in Spain, where they reached a new consensus and developed a guideline on the optimal therapy for treating periodontitis, the most serious periodontal disease and one of the most widespread chronic conditions in the world.
Chaired by renowned periodontist Prof. Mariano Sanz from Spain, Perio Workshop 2019 was held under the theme “Evidence-based guideline for periodontal therapy”. The expert attendees developed new guidance for dentists and oral healthcare professionals. Precise therapeutic pathways were identified based on the patient’s diagnosis and a set of recommendations were drawn up detailing specific interventions.
One key new approach was the recommendation of stepped care. Rather than following a sequential fixed order when treating a patient, the stepped care approach allows overlapping of several steps as it delivers the least complex and least resource-intensive therapy initially, and only moves to more complex or intensive therapies if monitoring of the patient shows that they are clinically indispensable.
The four working groups of experts at Perio Workshop 2019 considered 15 systematic reviews and a position paper on different aspects of periodontal therapy for Stages I, II and III of periodontitis and the maintenance of the successfully treated periodontitis patient. The workshop did not cover Stage IV periodontitis, as guidelines for this stage will be drawn up by Perio Workshop 2020 in November next year.
Besides focusing on the scientific evidence supporting the different interventions, the scientists considered their consistency and value, the clinical relevance of the outcomes, the balance of benefits and harms, patient preferences, and ethical, legal, economic and practical considerations.
The workshop benefited from the input of top-level specialists, not only from the EFP but from eight European scientific societies and organisations, representing key groups within the dental profession: the European Federation of Conservative Dentistry, the European Association of Dental Public Health, the European Society of Endodontology, the European Prosthodontic Association, the Council of European Dentists, the European Dental Hygienists Federation, the European Dental Students’ Association and the Platform for Better Oral Health in Europe.
The clinical guideline document drawn up by Perio Workshop 2019 will be published next year, along with other related papers, in a special open-access supplement to the Journal of Clinical Periodontology, official publication of the EFP.
“Perio Workshop 2019 was an important step forward both for periodontitis patients and for oral healthcare professionals,” said Sanz. “In the coming years, it will have a major impact on improving patient care by having identified the evidence supporting the different periodontal interventions, together with the adequate step-by-step approach to treatment approach,” he continued.
“The development of an EFP, S3 level, clinical practice guideline is a very important accomplishment for European periodontology,” added Dr David Herrera, who will chair Perio Workshop 2020. “We will now have a solid basis when designing the treatment plan in the management of patients with Stage I, II and III periodontitis. For Stage IV periodontitis, we will need to wait another year, and the EFP Workshop Committee is already working on the preparations for the generation of a guideline for such a significant condition.”